INTRODUCTION
Although the cellular events that accompany brain injury have been well characterized, the factors that mediate growth and repair in the CNS are only beginning to be identified. One such factor is basic fibroblast growth factor (FGF). Originally isolated from pituitary and brain extracts, the molecule has been recently shown to be almost ubiquitous in its distribution in tissues 5,la. It has also been shown to be particularly pleiotropic 4. As an example although it was first recognized for its ability to stimulate the proliferation of fibroblasts, it is an equally powerful (EDso -30 pg/ml) growth factor for endothelial cells, chondrocytes, smooth muscle cells, adrenocortical cells, Schwann cells, melanocytes, granulosa cells, astrocytes and oligodendrocytes 4,2°,~. Furthermore, it is a potent neurotropic factor capable of supporting survival of various neurons in cell culture 27,4°. Of even greater importance, the in vitro activities of basic FGF have invariably been shown to correlate with important in vivo functions when administered'to experimental animals 2,29. It is a potent angiogenic factor in models of neovascularization, stimulates cartilage repair, enhances peripheral and optic nerve regeneration and can prevent experimentally induced neuronal death in the CNS.
We have attempted to determine whether basic FGF is associated with the plasticity and regenerative capacity of the CNS by studying the effects of injury on basic FGE In most models of injury, polymorphonuclear leukocytes attract monocytes to the site of injury which then differentiate into macrophages; the macrophages are one of the most predominant and persistent cells associated with injury 6"s'sl. Because activated macrophages contain basic FGF a, they can presumably deliver this growth factor to the site of cell injury. Microglia of macrophage lineage and CNS origin migrate to the injured area and proliferate 17. Although, it is not known whether they produce basic FGF in vivo, they could potentially be providing the first stimulus for oligodendrocyte proliferation during the early phase of repair 11"26 and for astrocyte and endothelial cell proliferation during the later stages 1°, 26,28. A few recent studies have suggested that a common response to injury is its ability to increase basic FGE In peripheral tissues, the levels of growth factor are increased in wound fluid 22. Similarly, the cell proliferation that accompanies vascular injury also increases basic FGF 9. In the CNS, Logan ~ has reported that injury 292 increases the levels of immunoreactive and biologically active basic FGF and Finkelstein et al. have localized the increase to cells at the site of injury TM. We have extended these studies and examined the effect of CNS injury on basic FGF gene expression.
MATERIALS AND METHODS

Animals and surgery
Female Sprague-Dawley rats (200 g) were anesthetized (i.m.) with a mixture of acepromazine (1.875 mg/kg), ketamine (37.5 mg/kg) and xylazine (1.9 mg/kg). A 1.8 x 2.5 mm region of the fight cingulate and frontal cortex and corpus callosum was aspirated (0 to -1.8 AP, 0 to 2.5 ML to bregma). At 4 h, 1, 3, 7, or 14 days after surgery, animals (n = 3/group) were put under deep anesthesia then perfused transcardially with phosphate buffered saline containing 4% paraformaldehyde (PFA) and 0.05% glutaraldehyde using the pH shift method 3s. Brains were excised and further fixed in 10% sucrose and 4% PFA for 24 h. They were then snap frozen in OCT and stored at -80 °C. Sections (25/~m) were prepared from regions within and adjacent to the lesion, collected in cryoprotectant (20% glycerol and 30% ethylene glycol) and stored at -20 °C until used in either in situ hybridization studies for basic FGF mRNA or for the immunoloealization of basic FGF. The brains of three unlesioned rats and the contralateral side of the brain of each lesioned rat were processed and examined for comparative purposes.
Irnmunohistochemistry
The immunoperoxidase technique was used to stain and identify FGF-containing cells using the ABC Vectastain Elite kit (Vector Lab.). The primary antiserum raised against basic FGF(1-24) has been previously described 19. The IgG fraction was partially purified by protein-A Sepharose chromatography and used at 2.5 ~g/ml. Control sections were stained with the eluate of antibody that was not retained on basic FGF-Affi-gel columns.
In situ hybridization
The methods used for the in situ hybridization of basic FGF mRNA in the CNS have previously been described 12. The XhoIXhol fragment derived from rat basic FGF cDNA 36 was subcloned into a riboprobe and transcription of the antisense strand of the coding sequence performed using T7 polymerase in the presence of [35S]UTP. A [35S]UTP-labeled RNA probe encoding the sense strand of the 5" non-coding sequence was used for controls. Autoradiograms of the mounted sections were processed using Kodak XAR-5 film in order to obtain a macroscopic analysis of any changes in the distribution of basic FGF mRNA. For microscopic analysis, slides were exposed to a Kodak NTB-2 liquid autoradio- graph emulsion for 3 weeks, processed with Kodak D19 developer and rapid fixer, counterstained with haemotoxylin and examined by dark-field microscopy.
RESULTS
Detection of basic FGF mRNA after a lesion to the CNS
The distribution of basic FGF mRNA was examined in sections at or near the lesions at 4 h, 3, 7 and 14 days after injury. The pattern of distribution surrounding the injury is similar at all stages and a representative example at day 3 is shown in Fig. 1 . In all animals, basic FGF mRNA is detectable at 4 h, peaks at day 3 and persists up to 14 days in the region surrounding the lesion. Corresponding sections from control animals (not shown) or an examination of the contralateral side ( Fig. lg) of the lesioned animal reveals the expected 4 distribution of basic FGF mRNA in the indusium griseum and CA2 region of the hippocampus.
The basic FGF mRNA signal is most intense on the third day after injury and is detectable in cells lining the ipsilateral, but not in the contralateral ventricle (Fig. la) . This induction of mRNA is also detectable in sections anterior to the lesion and increased mRNA is only detected on the ipsilateral side (Fig. lc) . In both instances, the signal is absent in the corresponding region of control rats (not shown) or when sense strands are used as probes (Fig. lb,d ). When sections taken through the center of the lesion are examined (Fig. le) , there is a strong signal for basic FGF mRNA surrounding the lesion. No signal is present in adjacent sections that are hybridized with the sense probe (Fig. If) . When more caudal sections are examined, basic FGF mRNA is readily detected in the hippocampus on both the ipsilateral and contralateral sides (Fig. lg) . The ipsilateral hybridization however appears considerably more robust and different from the normal distribution of basic FGF mRNA we have previously reported 12. Adjacent sections, hybridized with the sense probe are negative (Fig. lh) .
Identification of loci of FGF mRNA expression
Microscopic examination of the brains 3 days after lesion confirmed that the detection of injury-associated basic FGF mRNA was confined to a select group of cells surrounding the lesion, in the hippocampus and in the lateral ventricle (Figs. 2-4) .
Loci surrounding the lesion. As shown in Fig. 2 , the cells that surround the lesion express basic FGF mRNA more strongly than those distal to the site of injury. Within the margin of the lesion, diverse but selective cells appear to express basic FGF mRNA (Fig. 2B,C) . The hybridization is specific since none is observed with the sense transcript. There was also no evidence for basic FGF mRNA expression in the contralateral cortex or in age and sex-matched controls.
Loci in the hippocampus. Unlike in the control hippocampus where basic FGF mRNA is restricted to the CA2 layer of cells 12, in the lesioned animals basic FGF mRNA is detected in all hippocampal layers throughout a 0.4 mm region caudal to the lesion. The strongest signal is observed in cells surrounding the hippocampal fissure (Fig. 3a) . There appears to be a specific induction of basic FGF mRNA in this area. First, no signal is detected with the sense probe (Fig. 3b) and second, an examination of and comparison with the contralateral side (see Fig. lg) shows that mRNA is distributed throughout the hippocampal region of the ipsilateral side and not only in the CA2 pyramidal neurons. Higher magnification of these FGF mRNA expressing cells reveals that, in bright field, grains are associated with large vessels rather than neurons and overlie cells that have morphological resemblance to macrophages and ameboid microglia (Fig. 4) . Although the injury induced the expression of basic FGF mRNA in regions which normally do not express detectable levels by in situ, the normal expression of basic FGF mRNA in the CA2 region was not affected by injury. 
Loci in the lateral ventricle. Ependymal cells lining the
lateral ventricle show a strong signal for basic FGF mRNA when examined anterior and ipsilateral to the lesion (Fig. 5a ). This signal was absent in the cells in the contralateral ventricle (Fig. 5b) and in sections labeled with the sense probe (not shown).
Basic FG F immunoreactivity after lesions
Immunocytochemical analysis of the distribution of basic FGF demonstrated that, throughout the time period examined (4 h to 2 weeks), the increase in basic FGF mRNA is accompanied by an increase in the number and staining intensity of immunopositive cells for basic FGF (Figs. 6-8 ).
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Immunoreactivity surrounding the lesion. At 3 days (Fig. 6a) , cells are extensively stained on the margin of the lesion when compared to the contralateral side or to comparative sections of other lesion time points. The staining is specific as illustrated by the inability of the flow through IgG to stain cells (Fig. 6b) . At this time point, some of the immunopositive cells have the features of macrophage-or ameboid microglia-like cells (see Fig.  8c as an example) but like in uninjured rat cingulate cortex and in the contralateral side of lesioned rats (not shown), neurons surrounding the margin of the lesion are immunopositive for basic FGF (Fig. 6a) . By 7 and 14 days after lesion, the cells that contain an immunoreactive basic FGF have more of the appearance of astrocytes and Immunoreactivity in the hippocampus. The immunohistochemical localization of basic FGF in the hippocampus confirmed the effect of the injury on FGF mRNA. As little as 4 h after surgery, at sites caudal to the cortical lesion and surrounding the hippocampal fissure, there is an appearance of basic FGF immunopositive cells in the anterior hippocampus (Fig. 7a) . This is in stark contrast to the unlesioned side where only neurons and a few scattered glial cells stained for basic FGF (Fig. 7c ).
Sections incubated with preabsorbed antisera did not stain for basic FGF (Fig. 7b,d ) and at other time points, the staining pattern was similar except that many of the basic FGF immunopositive cells were now hypertrophied (not shown).
Immunoreactivity lateral ventricle. Three days after the lesion, basic FGF immunoreactivity is also detected in ependymal cells (Fig. 8a) . At a higher magnification, the increased immunostaining surrounding the lesion appears to be largely attributable to immunopositive macrophagelike cells (Fig. 8c) . These cells also stain for the macrophage differentiation antigen MAC-1 (not shown) which is also present on ameboid microglia 17.
DISCUSSION
The results presented here establish that the injury associated with a cortical aspiration lesion increases basic FGF and its mRNA. They confirm earlier findings that this lesion increases immunoreactive basic FGF 14 and suggest that it is due to increased mRNA. Basic FGF mRNA is increased in the ependymal cells lining the lateral ventricle, in selected cells on the border of the lesion and in cells associated with the vessels of the hippocampal fissure. Whether the injury induces basic FGF gene transcription or enhanced mRNA stability has not been investigated. Clearly however, multiple cell types in the CNS have the capacity to express basic FGF mRNA in response to injury. Sections from control animals or from the contralateral side were consistently negative.
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The results presented here are certainly compatible with the suggestion that basic FGF may have a multifunctional role in promoting glial hypertrophy and proliferation 33 and in stimulating angiogenesis 21. At 3 days, many of the basic FGF-immunopositive cells are immunopositive for an antigen (MAC-l) common to cells of the monocyte-macrophage lineage, including ameboid microglia. This suggests that one of the cell-types synthesizing basic FGF is probably macrophage-derived. In addition to synthesizing basic FGF, these cells may acquire basic FGF from neuronal debris collected by phagocytosis. The detection of basic FGF immunoreactivity in these cells persisted over the course of the experiments and are consistent with the fact that there is an early extensive infiltration of macrophages and monocytes and proliferation of microglia in response to CNS injury 24. In lesioned rats, monocytes have previously been detected within hours after injury 17. These cells which acquire characteristics of microglia and macro- First and foremost, they stimulate angiogenesis 6 and glial proliferation 33'34. Because activated macrophages contain basic FGF 3, it is thus possible that, as part of the early phase of the regenerative process, basic FGF is available locally from monocytes and/or macrophages and helps initiate the response to CNS injury. Similar paradigms have been proposed for interleukin-1 (IL-1), a growth factor with 19-25% structural homology with basic FGF that is synthesized by macrophages 16m.
Of particular interest was the observation that the distribution of basic FGF mRNA and protein is affected in areas distal to the lesion. One mechanism that might account for these changes is if the lesions interfered with specific neuronal pathways. Deafferentation leads to aggregation and activation of microglia surrounding degenerating axons ~7'3° which in turn, stimulates the proliferation of astrocytes TM. While this process might explain changes in basic FGF expression in the hippocampus, it is more difficult to reconcile this mechanism with the increased basic FGF mRNA detected in ependymal cells of the lateral ventricle. Accordingly, it will be important to determine if the basic FGF that is localized in the ependyma is released by the injury into the third ventricle to accelerate the response to trauma.
The observation that basic FGF increases after CNS injury raises the question of how its synthesis and biological activities are eventually turned off when the healing process ends. This is particularly important for basic FGF in view of its ability to affect the function of diverse cell types in the CNS. Perhaps the failure of neurons to regenerate when cystic glial scars form 16 provides a clue to the regulation of FGF activity. The appearance of the scar coincides with the phagocytosis of the cellular debris derived from degenerating neurons, oligodendrocytes and other cells 17"3°. Basic FGF expression decreases at this time and it is interesting to speculate that the protein and glycosaminoglycan matrix REFERENCES in the scars acts much like the basement membrane of peripheral tissues, to sequester the remaining basic FGF. If this is the case, then these scars could be potentially deleterious by removing basic FGF from the normal neurotrophic milieu. This model is compatible with our recent observation that basic FGF is associated with the senile plaques that characterize Alzheimer's disease 39 and might explain the increased plasticity and regenerative capacity of the injured fetal and neonatal brain which fail to scar 7.
In the experiments described here, prior to day 7 there were only occasional astrocytes in the vicinity of the lesion that were basic FGF immunoreactive. In contrast, basic FGF-positive astrocytes became a major component of the lesion after day 7, a time that is coincident with extensive glial hypertrophy and development of the glial scar 1°. While in the normal brain, basic FGF is primarily present in neurons 32, in culture systems the reverse has been observed; only astrocytes produce detectable levels of basic FGF mRNA ~2. In this sense, the proliferating astrocytes in the area of the lesion resemble astrocytes in culture. Because reactive astrocytes have been shown to synthesize platelet-derived growth factor 35 nerve growth factor 15A6, fl-amyloid precursor protein 37, tumor necrosis factor, IL-1 and IL-623 presumably the collective delivery of these growth factors ultimately promotes wound healing. While, the potent neurotrophic activity of basic FGF suggests a role in neuronal sprouting and survival after injury 2'27'29"4°, it will remain of paramount importance to establish the functional significance of elevated basic FGF after CNS injury and during neuronal recovery to determine if it can be used as an adjunct to therapy.
